| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 38 |
| 1 | ERGOCALCIFEROL | 37 |
| 2 | ACETAMINOPHEN | 36 |
| 3 | DUPILUMAB | 33 |
| 4 | LEVOTHYROXINE SODIUM | 33 |
| 5 | ASPIRIN | 32 |
| 6 | ASPIRIN 325 MG | 32 |
| 7 | ASPIRIN 81 MG | 32 |
| 8 | TIRZEPATIDE | 27 |
| 9 | CETIRIZINE HYDROCHLORIDE | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HEATING PAD | 1 | 0.0667 |
| 1 | PEMIVIBART | 1 | 0.0233 |
| 2 | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL TABLETS | 1 | 0.0154 |
| 3 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 4 | SACROSIDASE | 1 | 0.0055 |
| 5 | FUTIBATINIB | 1 | 0.0045 |
| 6 | PSYLLIUM HUSK | 6 | 0.0044 |
| 7 | FIRST AID ANTIBIOTIC | 1 | 0.0042 |
| 8 | CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | 1 | 0.0040 |
| 9 | NAFARELIN ACETATE | 1 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 64 |
| 1 | Corticosteroid [EPC] | 62 |
| 2 | Benzodiazepine [EPC] | 45 |
| 3 | GLP-1 Receptor Agonist [EPC] | 44 |
| 4 | Kinase Inhibitor [EPC] | 37 |
| 5 | Provitamin D2 Compound [EPC] | 37 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 34 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 33 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 33 |
| 9 | Proton Pump Inhibitor [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sucrose-specific Enzyme [EPC] | 1 | 0.0055 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 2 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 3 | Gamma Secretase Inhibitor [EPC] | 2 | 0.0022 |
| 4 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 15 | 0.0022 |
| 5 | Interferon alfa-2b [EPC] | 3 | 0.0016 |
| 6 | Thyroid Hormone Receptor beta Agonist [EPC] | 3 | 0.0013 |
| 7 | Ectoparasiticide [EPC] | 5 | 0.0013 |
| 8 | Provitamin D2 Compound [EPC] | 37 | 0.0012 |
| 9 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |